IMPORTANT NOTE: You may submit your article only through our online submission systemSubmit your manuscript
  • Slider Image

Reviews 2005-2018

Immunotherapies for NSCLC: Are We Cutting the Gordian Helix? W.C.M. DEMPKE, L. SELLMANN, K. FENCHEL, K. EDVARDSEN (Munich; Mönchengladbach; Hamburg, Germany; Cambridge, UK). Anticancer Res 35: 5745-5757. 2015
Molecular Targeted Therapies in Hepatocellular Carcinoma: Past, Present and Future. M. STOTZ, A. GERGER, J. HAYBAECK, T. KIESSLICH, M.D. BULLOCK, M. PICHLER (Graz; Salzburg, Austria; Houston, TX, USA). Anticancer Res 35: 5737-5744. 2015
Atypical Fibroxanthoma - Histological Diagnosis, Immunohistochemical Markers and Concepts of Therapy. M. KOCH, A.J. FREUNDL, A. AGAIMY, F. KIESEWETTER, J. KÜNZEL, I. CICHA, C. ALEXIOU (Erlangen; Mainz, Germany). Anticancer Res 35: 5717-5735. 2015
Primary Thyroid Sarcoma: A Systematic Review. A. SUROV, S. GOTTSCHLING, A. WIENKE, H. JONAS MEYER, R.P. SPIELMANN, H. DRALLE (Halle-Wittenberg; Leipzig, Germany). Anticancer Res 35: 5185-5191. 2015
Predictive and Prognostic Value of the Tau Protein in Breast Cancer. C. BONNEAU, Z.A. GURARD-LEVIN, F. ANDRE, L. PUSZTAI, R. ROUZIER (Versailles; Paris, France; New Haven, CT, USA). Anticancer Res 35: 5179-5184. 2015
Hypofractionated Radiotherapy for Localized Prostate Cancer: A Challenging Accelerated Hypofractionated Radiotherapy. H. YAMAZAKI, S. NAKAMURA, G. SUZUKI, K. YOSHIDA, Y. YOSHIOKA, M. KOIZUMI, K. OGAWA (Kyoto; Takatsuki City; Suita, Japan). Anticancer Res 35: 5167-5177. 2015
Chronic Lymphocytic Leukemia: Current Concepts. E.-M. YU, A. KITTAI, I.A. TABBARA (Washington, DC, USA). Anticancer Res 35: 5149-5165. 2015
Nitric Oxide and Aggressive Behavior of Lung Cancer Cells. S. LUANPITPONG, P. CHANVORACHOTE (Bangkok, Thailand). Anticancer Res 35: 4585-4592. 2015
Second-line Treatment of Advanced Gastric Cancer: Current Options and Future Perspectives. P. CHROM, R. STEC, C. SZCZYLIK (Warsaw, Poland). Anticancer Res 35: 4575-4583. 2015
The Role of Methylation in Breast Cancer Susceptibility and Treatment. M.-C. POULIOT, Y. LABRIE, C. DIORIO, F. DUROCHER (Quebec, Canada). Anticancer Res 35: 4569-4574. 2015
Novel Molecular Targets for the Therapy of Urothelial Cancer. B.R.P. JANA, Y. ZHOU (Galveston, TX, USA). Anticancer Res 35: 4557-4567. 2015
Transcriptional Regulation of the p16 Tumor Suppressor Gene. Y. KOTAKE, M. NAEMURA, C. MURASAKI, Y. INOUE, H. OKAMOTO (Fukuoka, Japan). Anticancer Res 35: 4397-4401. 2015
Methods to Prevent or Treat Refractory Diseases by Focusing on Intestinal Microbes Using LPS and Macrophages. G.-I. SOMA, H. INAGAWA (Kagawa; Niigata, Japan). Anticancer Res 35: 4393-4396. 2015
Functional Alteration of Tumor-infiltrating Myeloid Cells in RNA Adjuvant Therapy. T. SEYA, H. SHIME, M. MATSUMOTO (Sapporo, Japan). Anticancer Res 35: 4385-4392. 2015
The Story of MCF-7 Breast Cancer Cell Line: 40 years of Experience in Research. Ş. COMŞA, A.M. CÎMPEAN, M. RAICA (Timisoara, Romania). Anticancer Res 35: 3147-3154. 2015
Anticancer Effects of Sandalwood (Santalum album). S. SANTHA, C. DWIVEDI (Brookings, SD, USA). Anticancer Res 35: 3137-3145. 2015
Histone Deacetylase (HDAC) Inhibitors: Current Evidence for Therapeutic Activities in Pancreatic Cancer. C. DAMASKOS, T. KARATZAS, L. NIKOLIDAKIS, I.D. KOSTAKIS, S. KARAMAROUDIS, G. BOUTSIKOS, Z. DAMASKOU, A. KOSTAKIS, G. KOURAKLIS (Athens, Greece). Anticancer Res 35: 3129-3135. 2015
Emergency Fertility Preservation for Female Patients with Cancer: Clinical Perspectives. M. SALAMA, P. MALLMANN (Cologne, Germany). Anticancer Res 35: 3117-3127. 2015
The Role of Human Papilloma Virus in Urological Malignancies. I. HEIDEGGER, W. BORENA, R. PICHLER (Innsbruck, Austria). Anticancer Res 35: 2513-2519. 2015
Targeted Therapy for NSCLC–A Double-edged Sword? W.C.M. DEMPKE (Munich, Germany). Anticancer Res 35: 2503-2512. 2015
Randomized Trials of Systemic Medically-treated Malignant Mesothelioma: A Systematic Review. C. BLOMBERG, J. NILSSON, G. HOLGERSSON, P. EDLUND, M. BERGQVIST, L. ADWALL, S. EKMAN, D. BRATTSTRÖM, S. BERGSTRÖM (Gävle; Uppsala; Umeå, Sweden). Anticancer Res 35: 2493-2501. 2015
Radiation-associated Cardiac Injury. R. ELDABAJE, D.L. LE, W. HUANG, L.-X. YANG (San Francisco, CA; Providence, RI, USA). Anticancer Res 35: 2487-2492. 2015
Recent Developments in Radiosensitization. J. LINAM, L.-X. YANG (San Francisco, CA, USA). Anticancer Res 35: 2479-2485. 2015
Diagnostic Potential of Ancillary Molecular Testing in Differentiation of Benign and Malignant Thyroid Nodules. P. BHATIA, A. DENIWAR, P. FRIEDLANDER, R. ASLAM, E. KANDIL (New Orleans, LA, USA). Anticancer Res 35: 1237-1241. 2015
Topics in Chemotherapy, Molecular-targeted Therapy, and Immunotherapy for Newly-diagnosed Glioblastoma Multiforme. N. OKONOGI, K. SHIRAI, T. OIKE, K. MURATA, S.-E. NODA, Y. SUZUKI, T. NAKANO (Maebashi; Fukushima, Japan). Anticancer Res 35: 1229-1235. 2015
Potential Anticancer Properties and Mechanisms of Action of Curcumin. N.G. VALLIANOU, A. EVANGELOPOULOS, N. SCHIZAS, C. KAZAZIS (Athens; Samos, Greece). Anticancer Res 35: 645-651. 2015
Mode of Action of Anticancer Peptides (ACPs) from Amphibian Origin. C. OELKRUG, M. HARTKE, A. SCHUBERT (Leipzig, Germany). Anticancer Res 35: 635-643. 2015
Targeting the Peritoneum with Novel Drug Delivery Systems in Peritoneal Carcinomatosis: A Review of the Literature. T.R. VAN OUDHEUSDEN, H. GRULL, P.Y.W. DANKER, I.H.J.T. DE HINGH (Eindhoven, the Netherlands). Anticancer Res 35: 627-634. 2015
Mechanisms and Clinical Significance of Histone Deacetylase Inhibitors: Epigenetic Glioblastoma Therapy. P. LEE, B. MURPHY, R. MILLER, V. MENON, N.L. BANIK, P. GIGLIO, S.M. LINDHORST, A.K. VARMA, W.A. VANDERGRIFT III, S.J. PATEL, A. DAS (Charleston, SC; Columbus, OH, USA). Anticancer Res 35: 615-625. 2015
Curcumin and Cancer Stem Cells: Curcumin Ηas Asymmetrical Effects on Cancer and Normal Stem Cells. P.P. SORDILLO, L. HELSON (Quakertown, PA, USA). Anticancer Res 35: 599-614. 2015
Cytokine Networks in Animal Models of Colitis-associated Cancer. E. ANTONIOU, G.A. MARGONIS, A. ANGELOU, G.C. ZOGRAFOS, E. PIKOULIS (Athens, Greece). Anticancer Res 35: 19-24. 2015
Female Genital Tract Chronic Graft-versus-Host Disease: Review of the Literature. A. CIAVATTINI, N. CLEMENTE (Ancona, Italy). Anticancer Res 35: 13-17. 2015
Management of Chronic Myelogenous Leukemia in Pregnancy. A. BHANDARI, K. ROLEN, B.K. SHAH (Lewiston, ID, USA). Anticancer Res 35: 1-11. 2015
Radiotherapeutic Treatment Approaches for Brain Metastases. F. DE FELICE, D. MUSIO, R. CASSESE, V. TOMBOLINI (Rome, Italy). Anticancer Res 34: (12) 6913-6918. 2014
Nuclear Receptors in Pancreatic Tumor Cells. C. DAMASKOS, T. KARATZAS, I.D. KOSTAKIS, L. NIKOLIDAKIS, A. KOSTAKIS, G. KOURAKLIS (Athens, Greece). Anticancer Res 34: (12) 6897-6911. 2014
Non Coding RNAs in Head and Neck Squamous Cell Carcinoma (HNSCC): A Clinical Perspective. N. DENARO, M.C. MERLANO, E. GRAZIOSO RUSSI, C. LO NIGRO (Cuneo, Italy). Anticancer Res 34: (12) 6887-6896. 2014
Transcatheter Arterial Embolic Therapies for Hepatocellular Carcinoma: A Literature Review. H. NISHIKAWA, R. KITA, T. KIMURA, Y. OSAKI (Osaka, Japan). Anticancer Res 34: 6877-6886. 2014
The Role of Dietary Factors in Prevention and Progression of Breast Cancer. R.E. ROSSI, M. PERICLEOUS, D. MANDAIR, T. WHYAND, M.E. CAPLIN (London, UK; Milano, Italy). Anticancer Res 34: 6861-6875. 2014
Bacteria: Prospective Savior in Battle against Cancer. N. NAIR, T. KASAI, M. SENO (Okayama, Japan). Anticancer Res 34: 6289-6296. 2014
Surgical Management of Microscopic Positive Resection Margin After Gastrectomy for Gastric Cancer: A Systematic Review of Gastric R1 Management. P. AURELLO, P. MAGISTRI, G. NIGRI, N. PETRUCCIANI, L. NOVI, L. ANTOLINO, F. D’ANGELO, G. RAMACCIATO (Rome, Italy). Anticancer Res 34: 6283-6288. 2014
Current Concepts in Colorectal Cancer Prevention with Cyclooxygenase Inhibitors. G. SINGH RANGER (Waterville, New Brunswick; Halifax, Nova Scotia, Canada). Anticancer Res 34: 6277-6286. 2014
Surgery for Symptomatic Colon Lipoma: A Systematic Review of the Literature. D. CROCETTI, P. SAPIENZA, A.V. STERPETTI, A. PALIOTTA, A. DE GORI, G. PEDULLÀ, G. DE TOMA (Rome, Italy). Anticancer Res 34: 6271-6276. 2014
Resistance to Abiraterone in Castration-resistant Prostate Cancer: A Review of the Literature. S. GIACINTI, M. BASSANELLI, A.M. ASCHELTER, A. MILANO, M. ROBERTO, P. MARCHETTI (Rome, Italy). Anticancer Res 34: 6265-6269. 2014
NOTCH Signaling Roles in Acute Myeloid Leukemia Cell Growth and Interaction with other Stemnessrelated Signals. S. TOHDA (Tokyo, Japan). Anticancer Res 34: 6259-6264. 2014
Chemotherapy of Rare Skin Adnexal Tumors: A Review of Literature. F.DE IULIIS, L. AMOROSO, L. TAGLIERI, S. VENDITTOZZI, L. BLASI, G. SALERNO, R. LANZA, S. SCARPA (Rome, Italy). Anticancer Res 34: 5263-5268. 2014
Soft Tissue Limb and Trunk Sarcomas: Diagnosis, Treatment and Follow-up. M. RASTRELLI, S. TROPEA, U. BASSO, A. ROMA, M. MARUZZO, C.R. ROSSI (Padova, Italy). Anticancer Res 34: 5251-5262. 2014
Pharmacogenomics in Lung Cancer Chemotherapy: A Review of What the Oncologist Should Know. C.D’ANTONIO, A. MILANO, R. RIGHINI, C.E. ONESTI, M. BASSANELLI, R. FALCONE, I. PARIS, S. LAURO, P. MARCHETTI (Rome, Italy). Anticancer Res 34: 5241-5250. 2014
Genes Associated with Succeptibility to Lung Adenocarcinoma Among Never Smokers Suggest the Mechanism of Disease. I. OKAZAKI, S. ISHIKAWA, Y. SOHARA (Tokyo; Otawara, Tochigi, Japan). Anticancer Res 34: 5229-5240. 2014
Neoadjuvant Strategy as Initial Treatment in Resectable Pancreatic Cancer: Concrete Evidence of Benefit. F. DE FELICE, D. MUSIO, N. RAFFETTO, V. TOMBOLINI (Rome, Italy). Anticancer Res 34: 4673-4676. 2014
The Intercellular Cell Adhesion Molecule-1 (ICAM-1) in Lung Cancer: Implications for Disease Progression and Prognosis. E.A. KOTTEAS, P. BOULAS, I. GKIOZOS, S. TSAGKOULI, G. TSOUKALA, K.N. SYRIGOS (Athens, Greece). Anticancer Res 34: 4665-4672. 2014
Page: 1 2 3 4 5 6 ... 7 8 9 10 11 12 
Custom Tables Plugin 05a1a29bdcae7b12229e651a9fd48b11

IMPORTANT NOTE: You may submit your article only through our online submission system